Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2009 June;61(3) > Minerva Pediatrica 2009 June;61(3):273-81





A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532




Minerva Pediatrica 2009 June;61(3):273-81

language: English

The chronic liver disease in patients with short bowel syndrome: etiology and treatment

Reinshagen K., Adams R., Trunk M., Wessel L. M.

1 Department of Pediatric Surgery Mannheim, Germany
2 Department of Pediatric and Adolescent Medicine, Mannheim, Germany
3 Department of Pathology, University Medical Centre, Mannheim, Germany


Short bowel syndrome is a life threatening disease with a high mortality and morbidity. Since home parenteral nutrition (PN) has been established, there is an increasing number of patients surviving the acute loss of bowel function. But on the long-time these patients suffer from different complications of PN, with loss of central venous access, recurrent sepsis and finally the syndrome of progressive cholestatic liver disease. Both loss of central venous access and especially the progressive cholestatic liver disease are the limiting factor for the long-term survival of patients suffering from intestinal failure. Interestingly, the pathophysiologic mechanisms of PN induced intrahepatic cholestasis have not been dissolved yet and seem to be of multifactorial genesis. Cholestasis has shown to be associated with prematurity, recurrent sepsis, enteral and PN, especially with lipid emulsions. Enteral feeding and a well-controlled regime of PN lower the incidence of end-stage liver disease and, therefore, has to be optimized in the therapy of these patients.

top of page

Publication History

Cite this article as

Corresponding author e-mail